- Home
- NVCR vs HUBG Comparison
NVCR vs HUBG Comparison
Compare NVCR & HUBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- HUBG
- Stock Information
- Founded
- NVCR 2000
- HUBG 1971
- Country
- NVCR Switzerland
- HUBG United States
- Employees
- NVCR N/A
- HUBG N/A
- Industry
- NVCR Medical/Dental Instruments
- HUBG Oil Refining/Marketing
- Sector
- NVCR Health Care
- HUBG Consumer Discretionary
- Exchange
- NVCR Nasdaq
- HUBG Nasdaq
- Market Cap
- NVCR 1.9B
- HUBG 2.1B
- IPO Year
- NVCR 2015
- HUBG 1996
- Fundamental
- Price
- NVCR $17.60
- HUBG $35.64
- Analyst Decision
- NVCR Buy
- HUBG Buy
- Analyst Count
- NVCR 7
- HUBG 9
- Target Price
- NVCR $32.43
- HUBG $43.57
- AVG Volume (30 Days)
- NVCR 1.4M
- HUBG 531.0K
- Earning Date
- NVCR 07-24-2025
- HUBG 07-31-2025
- Dividend Yield
- NVCR N/A
- HUBG 1.40%
- EPS Growth
- NVCR N/A
- HUBG N/A
- EPS
- NVCR N/A
- HUBG 1.70
- Revenue
- NVCR $621,711,000.00
- HUBG $3,862,113,000.00
- Revenue This Year
- NVCR $5.56
- HUBG N/A
- Revenue Next Year
- NVCR $9.19
- HUBG $6.96
- P/E Ratio
- NVCR N/A
- HUBG $21.01
- Revenue Growth
- NVCR 18.27
- HUBG N/A
- 52 Week Low
- NVCR $14.17
- HUBG $30.75
- 52 Week High
- NVCR $34.13
- HUBG $53.21
- Technical
- Relative Strength Index (RSI)
- NVCR 49.74
- HUBG 56.84
- Support Level
- NVCR $16.81
- HUBG $34.70
- Resistance Level
- NVCR $18.59
- HUBG $36.85
- Average True Range (ATR)
- NVCR 0.74
- HUBG 1.08
- MACD
- NVCR 0.08
- HUBG 0.23
- Stochastic Oscillator
- NVCR 56.18
- HUBG 72.25
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About HUBG Hub Group Inc.
Hub Group ranks among the largest providers of rail intermodal service. Roughly 60% of consolidated revenue comes from Hub's intermodal and transportation solutions division. ITS includes its flagship intermodal operations, which use the Class I rail carriers for the underlying line-haul movement of containers, as well as its dedicated truckload shipping unit. Hub's logistics segment includes its asset-light truck brokerage operations along with its outsourced transportation management, warehousing and fulfillment, and heavy-goods final mile delivery offerings. Hub often makes tuck-in acquisitions that expand its brokerage, last-mile, and dedicated offerings.